FI913892A0 - Nya, fraon blodplaettar haerledda b -kedjeanaloger av tillvaextfaktorn och foerfarande foer homogen framstaellning av dessa. - Google Patents

Nya, fraon blodplaettar haerledda b -kedjeanaloger av tillvaextfaktorn och foerfarande foer homogen framstaellning av dessa.

Info

Publication number
FI913892A0
FI913892A0 FI913892A FI913892A FI913892A0 FI 913892 A0 FI913892 A0 FI 913892A0 FI 913892 A FI913892 A FI 913892A FI 913892 A FI913892 A FI 913892A FI 913892 A0 FI913892 A0 FI 913892A0
Authority
FI
Finland
Prior art keywords
analogs
pdgf
present
tillvaextfaktorn
kedjeanaloger
Prior art date
Application number
FI913892A
Other languages
English (en)
Finnish (fi)
Inventor
Arlen Read Thomason
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/454,794 external-priority patent/US5149792A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of FI913892A0 publication Critical patent/FI913892A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
FI913892A 1989-12-19 1991-08-16 Nya, fraon blodplaettar haerledda b -kedjeanaloger av tillvaextfaktorn och foerfarande foer homogen framstaellning av dessa. FI913892A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/454,794 US5149792A (en) 1989-12-19 1989-12-19 Platelet-derived growth factor B chain analogs
US07/624,451 US5272064A (en) 1989-12-19 1990-12-13 DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
PCT/US1990/007451 WO1991008761A1 (fr) 1989-12-19 1990-12-17 Nouveaux analogues de chaine b de facteur de croissance derive de plaquettes et leur procede de production homogene

Publications (1)

Publication Number Publication Date
FI913892A0 true FI913892A0 (fi) 1991-08-16

Family

ID=27037609

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913892A FI913892A0 (fi) 1989-12-19 1991-08-16 Nya, fraon blodplaettar haerledda b -kedjeanaloger av tillvaextfaktorn och foerfarande foer homogen framstaellning av dessa.

Country Status (17)

Country Link
US (1) US5272064A (fr)
EP (1) EP0458959B1 (fr)
JP (1) JPH04504064A (fr)
AT (1) ATE123949T1 (fr)
AU (1) AU646014B2 (fr)
CA (1) CA2032675A1 (fr)
DE (1) DE69020335T2 (fr)
DK (1) DK0458959T3 (fr)
ES (1) ES2073735T3 (fr)
FI (1) FI913892A0 (fr)
GR (1) GR3017317T3 (fr)
IE (1) IE904608A1 (fr)
IL (1) IL96723A0 (fr)
NO (1) NO913232L (fr)
NZ (1) NZ236549A (fr)
PT (1) PT96272A (fr)
WO (1) WO1991008761A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016719A2 (fr) * 1992-02-26 1993-09-02 Allergan, Inc. Utilisation du facteur de croissance d'origine plaquettaire dans la cicatrisation de lesions ophtalmiques
IL105176A0 (en) * 1992-03-30 1993-07-08 Schering Corp Monomeric platelet-derived growth factor and prevention of stenosis or restenosis
EP1497444B1 (fr) 2002-03-27 2015-11-04 Immunex Corporation Procedes d'augmentation de la production de polypeptides
WO2004070018A2 (fr) * 2003-02-04 2004-08-19 Ludwig Institute For Cancer Research Modulation vegf-b et pdgf de cellules souches
US9132202B2 (en) 2009-07-17 2015-09-15 Aaron T. Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
CN103080300B (zh) 2010-08-05 2015-11-25 安姆根有限公司 增加细胞培养物的产率和活力的二肽
CA2833748C (fr) 2011-04-20 2019-07-16 Amgen Inc. Appareil auto-injecteur
US9133493B2 (en) 2011-04-21 2015-09-15 Amgen Inc. Method for culturing mammalian cells to improve recombinant protein production
PT2837680T (pt) 2011-07-01 2020-04-17 Amgen Inc Cultura celular de mamífero
AU2012301656A1 (en) 2011-09-02 2014-01-16 Amgen Inc. Pharmaceutical product and method of analysing light exposure of a pharmaceutical product
AR089231A1 (es) 2011-12-15 2014-08-06 Amgen Inc Metodo de floculacion
WO2014109858A1 (fr) 2013-01-14 2014-07-17 Amgen Inc. Méthodes d'utilisation d'inhibiteurs de cycle cellulaire pour moduler une ou plusieurs propriétés d'une culture cellulaire
PL2969099T5 (pl) 2013-03-14 2022-06-13 Amgen Inc. Usuwanie wypłukanego ligandu do oczyszczania na zasadzie powinowactwa
TWI832345B (zh) 2013-03-14 2024-02-11 美商安美基公司 用於增加重組蛋白質之甘露糖含量之方法
JP6336564B2 (ja) 2013-03-15 2018-06-06 アムゲン・インコーポレーテッド 薬物カセット、自動注入器、および自動注入器システム
TWI580452B (zh) 2013-03-15 2017-05-01 安美基公司 用於注射器之匣盒、注射器及使用包括自動注射器及匣盒之設備之方法
US9481901B2 (en) 2013-05-30 2016-11-01 Amgen Inc. Methods for increasing mannose content of recombinant proteins
AU2014342232B2 (en) 2013-10-31 2017-12-21 Amgen Inc. Use of monensin to regulate glycosylation of recombinant proteins
SG11201605640UA (en) 2014-01-13 2016-08-30 Amgen Inc Regulating ornithine metabolism to manipulate the high mannose glycoform content of recombinant proteins
KR102410393B1 (ko) 2014-01-29 2022-06-16 암젠 인크 재조합 단백질의 글리코실화를 조절하기 위한 n-글리코실화 경로 조절자의 과발현
US10106829B2 (en) 2014-01-29 2018-10-23 Amgen Inc. Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
ES2709994T3 (es) 2014-06-04 2019-04-22 Amgen Inc Métodos de recolección en cultivos de células de mamífero
MX2017006463A (es) 2014-11-19 2018-04-20 Amgen Inc Cuantificacion de porcion de glicano en glicoproteinas recombinantes.
ES2784503T3 (es) 2014-12-01 2020-09-28 Amgen Inc Procedimiento para manipular el nivel de contenido de glicano de una glicoproteína
EP3710089A1 (fr) 2017-11-16 2020-09-23 Amgen Inc. Auto-injecteur avec détection de décrochage et de point d'extrémité
WO2023079058A1 (fr) 2021-11-05 2023-05-11 Yokogawa Insilico Biotechnology Gmbh Culture cellulaire avec production réduite de lactate
WO2023129974A1 (fr) 2021-12-29 2023-07-06 Bristol-Myers Squibb Company Génération de lignées de cellules avec site d'intégration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor
EP0487116B1 (fr) * 1984-10-12 1999-12-29 ZymoGenetics, Inc. Analogues biologiquement actifs d'un facteur de croissance provenant de plaquettes sanguines dans des cellules eucaryotiques
US4801542A (en) * 1984-10-12 1989-01-31 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4766073A (en) * 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4769328A (en) * 1984-10-12 1988-09-06 Zymogenetics Inc. Expression of biologically active PDGF analogs in yeast
ATE131532T1 (de) * 1986-08-13 1995-12-15 Zymogenetics Inc Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen
DE3834079A1 (de) * 1988-10-06 1990-04-12 Biotechnolog Forschung Gmbh Wachstumstimulierendes pdgf-bb und dessen verwendung sowie ein verfahren zu seiner herstellung und der des monomeren
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems

Also Published As

Publication number Publication date
ES2073735T3 (es) 1995-08-16
NZ236549A (en) 1993-03-26
EP0458959A4 (en) 1993-06-16
NO913232D0 (no) 1991-08-19
US5272064A (en) 1993-12-21
IE904608A1 (en) 1991-06-19
DK0458959T3 (da) 1995-08-14
WO1991008761A1 (fr) 1991-06-27
GR3017317T3 (en) 1995-12-31
JPH04504064A (ja) 1992-07-23
DE69020335D1 (de) 1995-07-27
IL96723A0 (en) 1991-09-16
AU646014B2 (en) 1994-02-03
AU7153491A (en) 1991-07-18
ATE123949T1 (de) 1995-07-15
DE69020335T2 (de) 1995-11-02
NO913232L (no) 1991-08-19
PT96272A (pt) 1991-09-30
EP0458959A1 (fr) 1991-12-04
EP0458959B1 (fr) 1995-06-21
CA2032675A1 (fr) 1991-06-20

Similar Documents

Publication Publication Date Title
FI913892A0 (fi) Nya, fraon blodplaettar haerledda b -kedjeanaloger av tillvaextfaktorn och foerfarande foer homogen framstaellning av dessa.
Waterfield et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus
Gimenez-Gallego et al. The complete amino acid sequence of human brain-derived acidic fibroblast growth factor
AU638402B2 (en) Analogs of fibroblast growth factor
KR880701105A (ko) 신규 응혈촉진 단백질
DE69533556D1 (de) N-terminal modifizierte Polypeptide, und Herstellungsprozess
LU90408I2 (fr) Regranex-becaplermin
EP0722461A4 (fr) Expression de polypeptides de fusion transportes hors du cytoplasme sans sequence de tete
RU95113418A (ru) Полипептиды, способы получения, днк, вектор, клетка, применение полипептида, фармацевтические композиции
DE69632658D1 (de) Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom
DE3584579D1 (de) Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
ATE91722T1 (de) Pferde-gamma-interferon.
EP0546110A4 (en) New insulin-like growth factor binding protein igfbp-5
ATE145241T1 (de) Polypeptid, das zur interaktion mit thrombin fähig ist
ATE103931T1 (de) Polypeptide aus vipergift und deren genexpression.
Kim et al. Purification and characterization of a low molecular weight transforming growth factor from the urine of melanoma patients.
PT100651A (pt) Muteinas da interleucina 6 (il-6) isentas de cisteina
EP0072541A3 (fr) Interferons de leucocytes humains, procédé pour leur production microbiologique, intermédiaires et compositions les contenant
DE3782549D1 (de) Neue polypeptide, ihre herstellung und ihre verwendung.
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
JPS6437291A (en) Human cytochrome c gene and use thereof
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ATE241698T1 (de) Hst-2 mutein, dafür kodierende dns und herstellung
EP1679372A4 (fr) Nouveau polypeptide plexine, adn codant pour celui-ci et utilisation de celui-ci

Legal Events

Date Code Title Description
FD Application lapsed